Currently predicting for Thu, 4 Jun 2026

BLRX Prediction Chart

BLRX Predictions History

Latest community submissions for BLRX.
Predictor Target Session Target Price Result Direction Accuracy Score
Sindu Siva Sindu Siva @SinduSiva.199027
Feb 3, 2021 Bullish $3.10 X 1
Brandon Rahim Brandon Rahim @BrandonRahim.198996
Feb 3, 2021 Bullish $3.10 X 1
Feb 3, 2021 Bullish $3.10 X 1
Eran Drami Eran Drami @EranDrami.195829
Jan 29, 2021 Bearish $2.79 V 1
JS JS Pro
Jan 20, 2021 $3.28 -96.65% $2.45 X 66.12% 0
Baltzera Baltzera Merchant
Jan 20, 2021 Bullish $2.45 X 0
Walter Fordham Walter Fordham @WalterFordham.191166
Jan 20, 2021 Bearish $2.45 V 1
JS JS Pro
Dec 22, 2020 $2.67 -97.45% $2.62 V 98.09% 1
JS JS Pro
Dec 21, 2020 $2.58 -97.56% $2.64 V 97.73% 0
Alan Alan Pro @Alan.115878
Dec 21, 2020 $2.55 -97.59% $2.64 V 96.59% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for BLRX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT BIOLINERX LTD.
BioLineRx
BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in pat...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE